Metrics & More Article Recommendations * sı Supporting Information ABSTRACT: [Cp*IrL n Cl] complexes [L 1 = (methyl-β-D-glucopyranosid-2-yl)picolinamide, 1; L 2 = (methyl-3,4,6-tri-O-acetyl-β-D-glucopyranosid-2-yl)picolinamide, 2; L 3 = (2,3,4,6-tetra-Oacetyl-β-D-glucopyranosid-1-yl)picolinamide, 3] have been synthesized and completely characterized in solution, by 1D-and 2D-NMR spectroscopy, and in the solid state, by X-ray single crystal diffractometry. Despite the chirality of the L n -moiety and metal, a single diastereoisomer is observed for L 1 (1) and L 2 (2) having a (R)-iridium configuration: the pyranose moiety is oriented in a way to minimize the interactions of the axial protons, vicinal to the amide moiety, and Cp*, with the OMe-group pointing toward the Cp*-ligand and away from Ir−Cl. Such a diastereoisomer is also favored by the establishment of an O−H•••Cl−Ir hydrogen bond (2.356 Å) and by the minimization of the steric repulsion between one acetyl moiety of L 2 and Cp* and picolinamide ligands in 1 and 2, respectively. DFT calculations computed a stabilization by more than 5.9 and 3.1 kcal/mol of this diastereoisomer with respect to other possible ones. Two interconverting diastereoisomers with different chirality at iridium are instead observed in solution for complex 3 in which −CH 2 OAc [3a, 63%, (R)] and −OAc [3b, 37%, (S)] moieties, respectively, are oriented toward Cp* and N-arm of picolinamide ligands. Consistently, DFT calculations indicate that 3a and 3b have a comparable stability (ΔE = 1.2 kcal/mol). Complexes 1−3 catalyze the asymmetric transfer hydrogenation of RC(O)C(O)OH to RCH(OH)C(O)OH [R = Ph (PGA), CH 2 Ph (PPA), CH 2 (4-OH)C 6 H 4 (HPPA)], using both HCOOH and H 3 PO 3 as hydrogen donor, in water at pH 7 (by phosphate buffer), with excellent chemoselectivity and efficiency (conversion >99%) and moderate to good enantioselectivity (30− 70% ee). Utilizing catalyst 3 instead of 2, bearing the pseudoenantiomeric L 3 of L 2 ligand, causes a reduction of the percentage of the major enantiomer (R) with PGA and an inversion of stereoselectivity from (R) to (S) with PPA and HPPA substrates.